40
Participants
Start Date
November 30, 2009
Primary Completion Date
November 30, 2013
Study Completion Date
February 28, 2014
Plasmin (Human)
Plasmin (Human), 20 mg, delivered through a catheter into a thrombus
Plasmin (Human)
Plasmin (Human), 40 mg, delivered through a catheter into a thrombus
Plasmin (Human)
Plasmin (Human), 80 mg, delivered through a catheter into a thrombus
Royal Melbourne Hospital, Parkville
Heidelberg Repatriation Hospital, Melbourne, Heidelberg
O.O. Landes-Nervenklinik Wagner-Jauregg, Linz
Christian-Doppler-Klinik Salzburg,Universitätsklinik für Neurologie, Salzburg
Clinical Center of Serbia, Clinic for Vascular and Endovascular Surgery, Belgrade
"Special Hospital for Cerebrovascular Diseases Sveti Sava", Belgrade
Clinical Center Niš, Center of Radiology, Niš
Clinical Center of Vojvodina, Center for Radiology, Novi Sad
Hospital General Universitario Gregorio Marañon, Madrid
Hospital Universitario Ramón y Cajal, Madrid
Hôpital Rangueil, Toulouse
Clinical Center Kragujevac, Center for Radiology Diagnostic, Kragujevac
Hôpital Gui de Chauliac, Montpellier
Hôpital Gabriel Montpied, Clermont-Ferrand
Hôpital Bichat-Claude Bernard, Paris
Neurology Clinic, Faculty Hospital Nitra, Nitra
Neurology Clinic Hospital with Policlinic of F.D. Roosevelt, Banská Bystrica
I. Neurology Clinic, University Hospital Bratislava, Bratislava
Radiology Clinic, University Hospital Martin, Martin
Neurology Clinic, Central Military Faculty Hospital, Ružomberok
Hospital Universitario de Bellvitge, L'Hospitalet de Llobregat
Hospital Universitario Germans Trias i Pujol, Badalona
Hospital General Vall d'Hebron, Barcelona, Barcelona
Lead Sponsor
Grifols Therapeutics LLC
INDUSTRY